In our model of AF infection in immunosuppressed mice the recombinant human SAP had therapeutic efficacy at comparable doses to those used in lung fibrosis (84) and influenza (93), which fosters translation to prophylaxis and therapy of IPA in immune-compromised patients (94). The gene discussed is APCS; the disease is Ito hypomelanosis.